{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:49:26Z","timestamp":1778860166827,"version":"3.51.4"},"reference-count":118,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004484","name":"Tehran University of Medical Sciences","doi-asserted-by":"publisher","award":["1403-4-370-74703"],"award-info":[{"award-number":["1403-4-370-74703"]}],"id":[{"id":"10.13039\/501100004484","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Critical Reviews in Oncology\/Hematology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.critrevonc.2025.104930","type":"journal-article","created":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T14:14:51Z","timestamp":1757513691000},"page":"104930","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The critical role of homing in TIL therapy success: From biology to clinical application"],"prefix":"10.1016","volume":"216","author":[{"given":"Yousef","family":"Mohammadi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hossein","family":"Khorramdelazad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Narjes","family":"Soleimanifar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohsen","family":"Badalzadeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Hossein","family":"Nicknam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gholam Ali","family":"Kardar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.critrevonc.2025.104930_bib1","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.cell.2012.04.042","article-title":"A CXCL1 paracrine network links cancer chemoresistance and metastasis","volume":"150","author":"Acharyya","year":"2012","journal-title":"Cell"},{"issue":"15_suppl","key":"10.1016\/j.critrevonc.2025.104930_bib2","doi-asserted-by":"crossref","DOI":"10.1200\/JCO.2016.34.15_suppl.TPS9594","article-title":"A phase I\/II study of lymphodepletion plus adoptive cell transfer (ACT) with t cells transduced with CXCR2 and NGFR followed by high dose interleukin-2 (IL-2) in patients with metastatic melanoma (MM)","volume":"34","author":"Amaria","year":"2016","journal-title":"J. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.critrevonc.2025.104930_bib3","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.jcyt.2024.12.010","article-title":"Entering a new era of tumor-infiltrating lymphocyte cell therapy innovation","volume":"27","author":"Amaria","year":"2025","journal-title":"Cytotherapy"},{"issue":"41","key":"10.1016\/j.critrevonc.2025.104930_bib4","doi-asserted-by":"crossref","first-page":"14776","DOI":"10.1073\/pnas.1416498111","article-title":"Tissue injury and hypoxia promote malignant progression of prostate cancer by inducing CXCL13 expression in tumor myofibroblasts","volume":"111","author":"Ammirante","year":"2014","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"27","key":"10.1016\/j.critrevonc.2025.104930_bib5","doi-asserted-by":"crossref","first-page":"7551","DOI":"10.1073\/pnas.1600363113","article-title":"Tumor-associated fibroblasts predominantly come from local and not circulating precursors","volume":"113","author":"Arina","year":"2016","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.critrevonc.2025.104930_bib6","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1007\/s12031-011-9672-6","article-title":"The SDF-1 3\u2032 a genetic variation of the chemokine SDF-1\u03b1 (CXCL12) in parallel with its increased circulating levels is associated with susceptibility to MS: a study on Iranian multiple sclerosis patients","volume":"47","author":"Azin","year":"2012","journal-title":"J. Mol. Neurosci."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104930_bib7","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1159\/000494435","article-title":"CXCL12 and CXCR4 in the peripheral blood of patients with Parkinson\u2019s disease","volume":"25","author":"Bagheri","year":"2019","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/j.critrevonc.2025.104930_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/srep44384","article-title":"CCL2 nitration is a negative regulator of chemokine-mediated inflammation","volume":"7","author":"Barker","year":"2017","journal-title":"Sci. Rep."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104930_bib9","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00262-007-0355-7","article-title":"Adoptive transfer of autologous, HER2-specific, cytotoxic T lymphocytes for the treatment of HER2-overexpressing breast cancer","volume":"57","author":"Bernhard","year":"2008","journal-title":"Cancer Immunol. Immunother."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104930_bib10","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1002\/(SICI)1521-4141(200004)30:4<1102::AID-IMMU1102>3.0.CO;2-X","article-title":"ATF and jun transcription factors, acting through an Ets\/CRE promoter module, mediate lipopolysaccharide inducibility of the chemokine RANTES in monocytic mono mac 6 cells","volume":"30","author":"Boehlk","year":"2000","journal-title":"Eur. J. Immunol."},{"issue":"41","key":"10.1016\/j.critrevonc.2025.104930_bib11","doi-asserted-by":"crossref","first-page":"14825","DOI":"10.1073\/pnas.0503039102","article-title":"Induction of a proinflammatory program in normal human thyrocytes by the RET\/PTC1 oncogene","volume":"102","author":"Borrello","year":"2005","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104930_bib12","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1016\/j.cell.2018.01.004","article-title":"NK cells stimulate recruitment of cDC1 into the tumor microenvironment promoting cancer immune control","volume":"172","author":"B\u00f6ttcher","year":"2018","journal-title":"Cell"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104930_bib13","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2024-011119","article-title":"Role of high-dose interleukin-2 for melanoma in the age of cellular therapy","volume":"13","author":"Buchbinder","year":"2025","journal-title":"J. Immunother. Cancer"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104930_bib14","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/nm1699","article-title":"Endothelin b receptor mediates the endothelial barrier to T cell homing to tumors and disables immune therapy","volume":"14","author":"Buckanovich","year":"2008","journal-title":"Nat. Med."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104930_bib15","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/nm1699","article-title":"Endothelin B receptor mediates the endothelial barrier to t cell homing to tumors and disables immune therapy","volume":"14","author":"Buckanovich","year":"2008","journal-title":"Nat. Med."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104930_bib16","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.immuni.2004.12.008","article-title":"Homing phenotypes of tumor-specific CD8 T cells are predetermined at the tumor site by crosspresenting APCs","volume":"22","author":"Calzascia","year":"2005","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104930_bib17","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1084\/jem.20011502","article-title":"Rapid acquisition of tissue-specific homing phenotypes by CD4(+) T cells activated in cutaneous or mucosal lymphoid tissues","volume":"195","author":"Campbell","year":"2002","journal-title":"J. Exp. Med."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104930_bib18","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1038\/nm.3833","article-title":"Heparanase promotes tumor infiltration and antitumor activity of CAR-redirected T lymphocytes","volume":"21","author":"Caruana","year":"2015","journal-title":"Nat. Med."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104930_bib19","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/j.cmet.2018.02.024","article-title":"Increased tumor glycolysis characterizes immune resistance to adoptive T cell therapy","volume":"27","author":"Cascone","year":"2018","journal-title":"Cell Metab."},{"issue":"19","key":"10.1016\/j.critrevonc.2025.104930_bib20","doi-asserted-by":"crossref","first-page":"5671","DOI":"10.1158\/0008-5472.CAN-16-0144","article-title":"CCL2 produced by the glioma microenvironment is essential for the recruitment of regulatory T cells and myeloid-derived suppressor cells","volume":"76","author":"Chang","year":"2016","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.critrevonc.2025.104930_bib21","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1158\/2326-6066.CIR-16-0188","article-title":"CXCR2-dependent accumulation of tumor-associated neutrophils regulates T-cell immunity in pancreatic ductal adenocarcinoma","volume":"4","author":"Chao","year":"2016","journal-title":"Cancer Immunol. Res."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104930_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/hep.28655","article-title":"Hypoxia induces myeloid-derived suppressor cell recruitment to hepatocellular carcinoma through chemokine (C-C motif) ligand 26","volume":"64","author":"Chiu","year":"2016","journal-title":"Hepatology"},{"issue":"7","key":"10.1016\/j.critrevonc.2025.104930_bib23","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/nrc2868","article-title":"Targeting the tumour vasculature: insights from physiological angiogenesis","volume":"10","author":"Chung","year":"2010","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104930_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2025.189312","article-title":"Tertiary lymphoid structures achieve 'cold' to 'hot' transition by remodeling the cold tumor microenvironment","volume":"1880","author":"Cui","year":"2025","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"23","key":"10.1016\/j.critrevonc.2025.104930_bib25","doi-asserted-by":"crossref","first-page":"7176","DOI":"10.1158\/0008-5472.CAN-11-1301","article-title":"Egfl7 promotes tumor escape from immunity by repressing endothelial cell activation","volume":"71","author":"Delfortrie","year":"2011","journal-title":"Cancer Res."},{"issue":"25","key":"10.1016\/j.critrevonc.2025.104930_bib26","doi-asserted-by":"crossref","first-page":"6392","DOI":"10.1182\/blood-2009-03-209650","article-title":"T lymphocytes coexpressing CCR4 and a chimeric antigen receptor targeting CD30 have improved homing and antitumor activity in a hodgkin tumor model","volume":"113","author":"Di Stasi","year":"2009","journal-title":"Blood"},{"issue":"11","key":"10.1016\/j.critrevonc.2025.104930_bib27","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ni1102-991","article-title":"Cancer immunoediting: from immunosurveillance to tumor escape","volume":"3","author":"Dunn","year":"2002","journal-title":"Nat. Immunol."},{"issue":"7355","key":"10.1016\/j.critrevonc.2025.104930_bib28","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nature10169","article-title":"Tumour hypoxia promotes tolerance and angiogenesis via CCL28 and treg cells","volume":"475","author":"Facciabene","year":"2011","journal-title":"Nature"},{"issue":"50","key":"10.1016\/j.critrevonc.2025.104930_bib29","doi-asserted-by":"crossref","first-page":"20212","DOI":"10.1073\/pnas.1320318110","article-title":"Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti-PD-L1 immunotherapy in pancreatic cancer","volume":"110","author":"Feig","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"50","key":"10.1016\/j.critrevonc.2025.104930_bib30","doi-asserted-by":"crossref","first-page":"20212","DOI":"10.1073\/pnas.1320318110","article-title":"Targeting CXCL12 from FAP-expressing carcinoma-associated fibroblasts synergizes with anti\u2013PD-L1 immunotherapy in pancreatic cancer","volume":"110","author":"Feig","year":"2013","journal-title":"Proc. Natl. Acad. Sci."},{"issue":"13","key":"10.1016\/j.critrevonc.2025.104930_bib31","doi-asserted-by":"crossref","first-page":"3672","DOI":"10.1158\/0008-5472.CAN-17-0236","article-title":"Expansion of Tumor-Infiltrating CD8+ T cells expressing PD-1 improves the efficacy of adoptive T-cell therapy","volume":"77","author":"Fernandez-Poma","year":"2017","journal-title":"Cancer Res."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104930_bib32","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1200\/JCO.1989.7.2.250","article-title":"Tumor localization of adoptively transferred indium-111 labeled tumor infiltrating lymphocytes in patients with metastatic melanoma","volume":"7","author":"Fisher","year":"1989","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104930_bib33","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1177\/039463200601900406","article-title":"Endothelial cell anergy is mediated by bFGF through the sustained activation of p38-MAPK and NF-\u03baB inhibition","volume":"19","author":"Flati","year":"2006","journal-title":"Int. J. Immunopathol. Pharmacol."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104930_bib34","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/s41573-018-0007-y","article-title":"Approaches to treat immune hot, altered and cold tumours with combination immunotherapies","volume":"18","author":"Galon","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.critrevonc.2025.104930_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2019.154942","article-title":"PEGylation of a glycosaminoglycan-binding, dominant-negative CXCL8 mutant retains bioactivity in vitro and in vivo","volume":"127","author":"Gerlza","year":"2020","journal-title":"Cytokine"},{"issue":"16","key":"10.1016\/j.critrevonc.2025.104930_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14163906","article-title":"Cancer-associated fibroblasts: tumorigenicity and targeting for cancer therapy","volume":"14","author":"Glabman","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"15","key":"10.1016\/j.critrevonc.2025.104930_bib37","doi-asserted-by":"crossref","first-page":"3826","DOI":"10.3390\/cancers14153826","article-title":"Chemokine receptor expression on T cells is modulated by CAFs and chemokines affect the spatial distribution of T cells in pancreatic tumors","volume":"14","author":"Gorchs","year":"2022","journal-title":"Cancers"},{"issue":"22","key":"10.1016\/j.critrevonc.2025.104930_bib38","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1093\/jnci\/81.22.1709","article-title":"In vivo distribution of adoptively transferred Indium- 111- labeled tumor infiltrating lymphocytes and peripheral blood lymphocytes in patients with metastatic melanoma","volume":"81","author":"Griffith","year":"1989","journal-title":"JNCI J. Natl. Cancer Inst."},{"key":"10.1016\/j.critrevonc.2025.104930_bib39","doi-asserted-by":"crossref","DOI":"10.3389\/fcell.2021.657158","article-title":"Breast tumor-derived exosomal MicroRNA-200b-3p promotes specific organ metastasis through regulating CCL2 expression in lung epithelial cells","volume":"9","author":"Gu","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"issue":"7193","key":"10.1016\/j.critrevonc.2025.104930_bib40","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/nature06868","article-title":"Vascular normalization in Rgs5-deficient tumours promotes immune destruction","volume":"453","author":"Hamzah","year":"2008","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.critrevonc.2025.104930_bib41","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1158\/0008-5472.CAN-08-2281","article-title":"Chemokine expression in melanoma metastases associated with CD8+ T-cell recruitment","volume":"69","author":"Harlin","year":"2009","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104930_bib42","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.arcmed.2010.07.001","article-title":"Assessment of CXCL12 (SDF-1\u03b1) polymorphisms and its serum level in posttransfusion occult HBV-infected patients in southeastern Iran","volume":"41","author":"Hassanshahi","year":"2010","journal-title":"Arch. Med. Res."},{"issue":"22","key":"10.1016\/j.critrevonc.2025.104930_bib43","doi-asserted-by":"crossref","first-page":"6997","DOI":"10.1158\/0008-5472.CAN-11-1466","article-title":"Chemotherapy induces intratumoral expression of chemokines in cutaneous melanoma, favoring T-cell infiltration and tumor control","volume":"71","author":"Hong","year":"2011","journal-title":"Cancer Res."},{"issue":"12","key":"10.1016\/j.critrevonc.2025.104930_bib44","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1158\/1078-0432.CCR-17-1365","article-title":"T-cell homing therapy for reducing regulatory T cells and preserving effector T-cell function in large solid tumors","volume":"24","author":"Hu","year":"2018","journal-title":"Clin. Cancer Res."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104930_bib45","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1096\/fj.14-250985","article-title":"VEGF suppresses T-lymphocyte infiltration in the tumor microenvironment through inhibition of NF-\u03baB-induced endothelial activation","volume":"29","author":"Huang","year":"2015","journal-title":"Faseb J."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104930_bib46","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1096\/fj.14-250985","article-title":"VEGF suppresses T-lymphocyte infiltration in the tumor microenvironment through inhibition of NF-\u03baB-induced endothelial activation","volume":"29","author":"Huang","year":"2015","journal-title":"FASEB J."},{"issue":"12","key":"10.1016\/j.critrevonc.2025.104930_bib47","doi-asserted-by":"crossref","first-page":"8064","DOI":"10.4049\/jimmunol.178.12.8064","article-title":"Regulated shedding of transmembrane chemokines by the disintegrin and metalloproteinase 10 facilitates detachment of adherent leukocytes","volume":"178","author":"Hundhausen","year":"2007","journal-title":"J. Immunol."},{"key":"10.1016\/j.critrevonc.2025.104930_bib48","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.3389\/fimmu.2016.00613","article-title":"T cell trafficking through lymphatic vessels","volume":"7","author":"Hunter","year":"2016","journal-title":"Front. Immunol."},{"issue":"8","key":"10.1016\/j.critrevonc.2025.104930_bib49","article-title":"Chemokine receptor engineering of t cells with CXCR2 improves homing towards subcutaneous human melanomas in xenograft mouse model","volume":"7","author":"Idorn","year":"2018","journal-title":"OncoImmunology"},{"issue":"12","key":"10.1016\/j.critrevonc.2025.104930_bib50","doi-asserted-by":"crossref","first-page":"2990","DOI":"10.1158\/0008-5472.CAN-11-4062","article-title":"Inhibitory roles of signal transducer and activator of transcription 3 in antitumor immunity during carcinogen-Induced lung tumorigenesis","volume":"72","author":"Ihara","year":"2012","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104930_bib51","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2020-000528","article-title":"Cell death induced by cytotoxic CD8(+) t cells is immunogenic and primes caspase-3-dependent spread immunity against endogenous tumor antigens","volume":"8","author":"Jaime-Sanchez","year":"2020","journal-title":"J. Immunother. Cancer"},{"issue":"24","key":"10.1016\/j.critrevonc.2025.104930_bib52","doi-asserted-by":"crossref","first-page":"6452","DOI":"10.1158\/1078-0432.CCR-14-1236","article-title":"Clever-1\/Stabilin-1 controls cancer growth and metastasis","volume":"20","author":"Karikoski","year":"2014","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104930_bib53","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/s41556-018-0256-3","article-title":"Chemotherapy elicits pro-metastatic extracellular vesicles in breast cancer models","volume":"21","author":"Keklikoglou","year":"2019","journal-title":"Nat. Cell Biol."},{"issue":"19","key":"10.1016\/j.critrevonc.2025.104930_bib54","doi-asserted-by":"crossref","first-page":"10175","DOI":"10.1080\/07391102.2023.2256406","article-title":"Antitumor activities of a novel fluorinated small molecule (A1) in CT26 colorectal cancer cells: molecular docking and in vitro studies","volume":"42","author":"Khorramdelazad","year":"2024","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104930_bib55","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1172\/JCI90644","article-title":"Isocitrate dehydrogenase mutations suppress STAT1 and CD8+ t cell accumulation in gliomas","volume":"127","author":"Kohanbash","year":"2017","journal-title":"J. Clin. Investig."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104930_bib56","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1038\/s41467-017-00147-w","article-title":"Evasion of immunosurveillance by genomic alterations of PPAR\u03b3\/RXR\u03b1 in bladder cancer","volume":"8","author":"Korpal","year":"2017","journal-title":"Nat. Commun."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104930_bib57","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.cell.2017.11.013","article-title":"Myc cooperates with ras by programming inflammation and immune suppression","volume":"171","author":"Kortlever","year":"2017","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104930_bib58","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1016\/j.ccell.2019.02.008","article-title":"KRAS-IRF2 axis drives immune suppression and immune therapy resistance in colorectal cancer","volume":"35","author":"Liao","year":"2019","journal-title":"Cancer Cell"},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104930_bib59","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00262-013-1506-7","article-title":"Type I interferons induced by radiation therapy mediate recruitment and effector function of CD8+ t cells","volume":"63","author":"Lim","year":"2014","journal-title":"Cancer Immunol. Immunother."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104930_bib60","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.yexcr.2017.08.031","article-title":"ATF4 regulates CCL2 expression to promote endometrial cancer growth by controlling macrophage infiltration","volume":"360","author":"Liu","year":"2017","journal-title":"Exp. Cell Res."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104930_bib61","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1038\/s41467-022-30392-7","article-title":"Rapid acceleration of KRAS-mutant pancreatic carcinogenesis via remodeling of tumor immune microenvironment by PPAR\u03b4","volume":"13","author":"Liu","year":"2022","journal-title":"Nat. Commun."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104930_bib62","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.4049\/jimmunol.180.5.3132","article-title":"Radiation-Induced IFN-\u03b3 production within the tumor microenvironment influences antitumor Immunity1","volume":"180","author":"Lugade","year":"2008","journal-title":"J. Immunol."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104930_bib63","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1158\/0008-5472.CAN-13-1265","article-title":"CCL2\/CCR2-Dependent recruitment of functional antigen-presenting cells into tumors upon chemotherapy","volume":"74","author":"Ma","year":"2014","journal-title":"Cancer Res."},{"issue":"11","key":"10.1016\/j.critrevonc.2025.104930_bib64","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/s00262-024-03793-4","article-title":"Recent clinical researches and technological development in TIL therapy","volume":"73","author":"Matsueda","year":"2024","journal-title":"Cancer Immunol. Immunother."},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104930_bib65","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.4049\/jimmunol.181.5.3099","article-title":"Radiation-Induced CXCL16 release by breast cancer cells attracts effector T Cells1","volume":"181","author":"Matsumura","year":"2008","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104930_bib66","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41568-023-00635-w","article-title":"How chemokines organize the tumour microenvironment","volume":"24","author":"Mempel","year":"2024","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.critrevonc.2025.104930_bib67","series-title":"Melanoma: A Modern Multidisciplinary Approach","first-page":"549","article-title":"Adoptive cell therapy for melanoma","author":"Mills","year":"2018"},{"issue":"Suppl 4","key":"10.1016\/j.critrevonc.2025.104930_bib68","doi-asserted-by":"crossref","first-page":"S133","DOI":"10.1016\/j.bjorl.2022.09.007","article-title":"CD45RO+TILs: cellular biomarkers for larynx squamous cell carcinoma outcome","volume":"88","author":"Mohammadi","year":"2022","journal-title":"Braz. J. Otorhinolaryngol."},{"key":"10.1016\/j.critrevonc.2025.104930_bib69","doi-asserted-by":"crossref","first-page":"S133","DOI":"10.1016\/j.bjorl.2022.09.007","article-title":"CD45RO+TILs: cellular biomarkers for larynx squamous cell carcinoma outcome","volume":"88","author":"Mohammadi","year":"2022","journal-title":"Braz. J. Otorhinolaryngol."},{"key":"10.1016\/j.critrevonc.2025.104930_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneuroim.2025.578669","article-title":"Prognostic significance of PD-L1 and CD45RO+ cells in glioblastoma: the modulating role of MMR status","volume":"406","author":"Mohammadi","year":"2025","journal-title":"J. Neuroimmunol."},{"issue":"10","key":"10.1016\/j.critrevonc.2025.104930_bib71","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.1084\/jem.20101956","article-title":"Chemokine nitration prevents intratumoral infiltration of antigen-specific T cells","volume":"208","author":"Molon","year":"2011","journal-title":"J. Exp. Med."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104930_bib72","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1158\/2326-6066.CIR-18-0633","article-title":"CCR2-Dependent recruitment of tregs and monocytes following radiotherapy is associated with TNF\u03b1-mediated resistance","volume":"7","author":"Mondini","year":"2019","journal-title":"Cancer Immunol. Res."},{"issue":"14","key":"10.1016\/j.critrevonc.2025.104930_bib73","doi-asserted-by":"crossref","first-page":"4719","DOI":"10.1158\/1078-0432.CCR-11-0351","article-title":"Expression of a functional CCR2 receptor enhances tumor localization and tumor eradication by retargeted human T cells expressing a mesothelin-specific chimeric antibody receptor","volume":"17","author":"Moon","year":"2011","journal-title":"Clin. Cancer Res."},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104930_bib74","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1158\/0008-5472.CAN-15-1938","article-title":"PRC2 epigenetically silences Th1-Type chemokines to suppress effector T-cell trafficking in colon cancer","volume":"76","author":"Nagarsheth","year":"2016","journal-title":"Cancer Res."},{"key":"10.1016\/j.critrevonc.2025.104930_bib75","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s10147-017-1187-x","article-title":"Biological\/pathological functions of the CXCL12\/CXCR4\/CXCR7 axes in the pathogenesis of bladder cancer","volume":"22","author":"Nazari","year":"2017","journal-title":"Int. J. Clin. Oncol."},{"issue":"7","key":"10.1016\/j.critrevonc.2025.104930_bib76","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14071681","article-title":"Dual effect of immune cells within tumour microenvironment: pro- and anti-tumour effects and their triggers","volume":"14","author":"Pe\u00f1a-Romero","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"11","key":"10.1016\/j.critrevonc.2025.104930_bib77","doi-asserted-by":"crossref","first-page":"4063","DOI":"10.1172\/JCI82152","article-title":"LKB1 loss promotes endometrial cancer progression via CCL2-dependent macrophage recruitment","volume":"125","author":"Pe\u00f1a","year":"2015","journal-title":"J. Clin. Invest."},{"issue":"7577","key":"10.1016\/j.critrevonc.2025.104930_bib78","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nature15520","article-title":"Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy","volume":"527","author":"Peng","year":"2015","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.critrevonc.2025.104930_bib79","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1158\/2159-8290.CD-15-0283","article-title":"Loss of PTEN promotes resistance to t Cell-Mediated immunotherapy","volume":"6","author":"Peng","year":"2016","journal-title":"Cancer Discov."},{"issue":"22","key":"10.1016\/j.critrevonc.2025.104930_bib80","doi-asserted-by":"crossref","first-page":"5458","DOI":"10.1158\/1078-0432.CCR-10-0712","article-title":"Transduction of tumor-specific t cells with CXCR2 chemokine receptor improves migration to tumor and antitumor immune responses","volume":"16","author":"Peng","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.critrevonc.2025.104930_bib81","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.621254","article-title":"The natural killer\u2013dendritic cell immune axis in anti-cancer immunity and immunotherapy","volume":"11","author":"Peterson","year":"2021","journal-title":"Front. Immunol."},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104930_bib82","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1002\/1097-0142(19940315)73:6<1731::AID-CNCR2820730630>3.0.CO;2-H","article-title":"Localization of 111Indium-labeled tumor infiltrating lymphocytes to tumor in patients receiving adoptive immunotherapy. Augmentation with cyclophosphamide and correlation with response","volume":"73","author":"Pockaj","year":"1994","journal-title":"Cancer"},{"issue":"13","key":"10.1016\/j.critrevonc.2025.104930_bib83","doi-asserted-by":"crossref","first-page":"3554","DOI":"10.1182\/blood.V98.13.3554","article-title":"Amino-terminal truncation of CXCR3 agonists impairs receptor signaling and lymphocyte chemotaxis, while preserving antiangiogenic properties","volume":"98","author":"Proost","year":"2001","journal-title":"Blood"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104930_bib84","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2025-011609","article-title":"Targeting nerve growth factor: an achilles' heel for tumors?","volume":"13","author":"Repasky","year":"2025","journal-title":"J. Immunother. Cancer"},{"issue":"22","key":"10.1016\/j.critrevonc.2025.104930_bib85","doi-asserted-by":"crossref","first-page":"13800","DOI":"10.1074\/jbc.M115.638395","article-title":"Cysteine cathepsins activate ELR chemokines and inactivate non-ELR chemokines","volume":"290","author":"Repnik","year":"2015","journal-title":"J. Biol. Chem."},{"issue":"8","key":"10.1016\/j.critrevonc.2025.104930_bib86","first-page":"926","article-title":"PPARs and molecular mechanisms of transrepression","volume":"1771","author":"Ricote","year":"2007","journal-title":"Biochim. Biophys. Acta (BBA) Mol. Cell Biol. Lipids"},{"issue":"25","key":"10.1016\/j.critrevonc.2025.104930_bib87","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1056\/NEJM198812223192527","article-title":"Use of tumor-infiltrating lymphocytes and interleukin-2 in the immunotherapy of patients with metastatic melanoma. A preliminary report","volume":"319","author":"Rosenberg","year":"1988","journal-title":"N. Engl. J. Med."},{"issue":"4770","key":"10.1016\/j.critrevonc.2025.104930_bib88","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1126\/science.3489291","article-title":"A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes","volume":"233","author":"Rosenberg","year":"1986","journal-title":"Science"},{"issue":"12","key":"10.1016\/j.critrevonc.2025.104930_bib89","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.3390\/cancers17121945","article-title":"Next-Generation CAR-T and TCR-T cell therapies for solid tumors: innovations, challenges, and global development trends","volume":"17","author":"Sanomachi","year":"2025","journal-title":"Cancers"},{"issue":"10","key":"10.1016\/j.critrevonc.2025.104930_bib90","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1007\/s00262-012-1245-1","article-title":"CXCR1 as a novel target for directing reactive t cells toward melanoma: implications for adoptive cell transfer immunotherapy","volume":"61","author":"Sapoznik","year":"2012","journal-title":"Cancer Immunol. Immunother."},{"issue":"7","key":"10.1016\/j.critrevonc.2025.104930_bib91","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1158\/2326-6066.CIR-13-0202","article-title":"ERK-Dependent downregulation of the atypical chemokine receptor D6 drives tumor aggressiveness in kaposi sarcoma","volume":"2","author":"Savino","year":"2014","journal-title":"Cancer Immunol. Res."},{"issue":"3","key":"10.1016\/j.critrevonc.2025.104930_bib92","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0002-9440(10)64951-6","article-title":"Papillary carcinoma of the thyroid: hepatocyte growth factor (HGF) stimulates tumor cells to release chemokines active in recruiting dendritic cells","volume":"156","author":"Scarpino","year":"2000","journal-title":"Am. J. Pathol."},{"issue":"7598","key":"10.1016\/j.critrevonc.2025.104930_bib93","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1038\/nature17403","article-title":"The necrosome promotes pancreatic oncogenesis via CXCL1 and mincle-induced immune suppression","volume":"532","author":"Seifert","year":"2016","journal-title":"Nature"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104930_bib94","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.cell.2015.09.001","article-title":"Nuclear FAK controls chemokine transcription, tregs, and evasion of anti-tumor immunity","volume":"163","author":"Serrels","year":"2015","journal-title":"Cell"},{"issue":"17","key":"10.1016\/j.critrevonc.2025.104930_bib95","doi-asserted-by":"crossref","first-page":"5038","DOI":"10.1158\/0008-5472.CAN-18-0365","article-title":"Oncogenic BRAFV600E governs regulatory T-cell recruitment during melanoma tumorigenesis","volume":"78","author":"Shabaneh","year":"2018","journal-title":"Cancer Res."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104930_bib96","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.immuni.2017.12.014","article-title":"Activation of p53 in immature myeloid precursor cells controls differentiation into Ly6c+CD103+ monocytic antigen-presenting cells in tumors","volume":"48","author":"Sharma","year":"2018","journal-title":"Immunity"},{"issue":"11","key":"10.1016\/j.critrevonc.2025.104930_bib97","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/nm.3708","article-title":"Cancer cell\u2013autonomous contribution of type I interferon signaling to the efficacy of chemotherapy","volume":"20","author":"Sistigu","year":"2014","journal-title":"Nat. Med."},{"issue":"7559","key":"10.1016\/j.critrevonc.2025.104930_bib98","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nature14404","article-title":"Melanoma-intrinsic \u03b2-catenin signalling prevents anti-tumour immunity","volume":"523","author":"Spranger","year":"2015","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104930_bib99","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.ccell.2017.04.003","article-title":"Tumor-Residing Batf3 dendritic cells are required for effector t cell trafficking and adoptive t cell therapy","volume":"31","author":"Spranger","year":"2017","journal-title":"Cancer Cell"},{"issue":"200","key":"10.1016\/j.critrevonc.2025.104930_bib100","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3006504","article-title":"Up-regulation of PD-L1, IDO, and T(regs) in the melanoma tumor microenvironment is driven by CD8(+) t cells","volume":"5","author":"Spranger","year":"2013","journal-title":"Sci. Transl. Med."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104930_bib101","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1038\/s41590-023-01443-y","article-title":"T cell egress via lymphatic vessels is tuned by antigen encounter and limits tumor control","volume":"24","author":"Steele","year":"2023","journal-title":"Nat. Immunol."},{"issue":"7","key":"10.1016\/j.critrevonc.2025.104930_bib102","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1158\/0008-5472.CAN-16-1755","article-title":"Myeloid cells that impair immunotherapy are restored in melanomas with acquired resistance to BRAF inhibitors","volume":"77","author":"Steinberg","year":"2017","journal-title":"Cancer Res."},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104930_bib103","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1093\/jnci\/djy234","article-title":"Impact of epithelial\u2013stromal interactions on peritumoral fibroblasts in ductal carcinoma in situ","volume":"111","author":"Strell","year":"2019","journal-title":"JNCI J. Natl. Cancer Inst."},{"issue":"4","key":"10.1016\/j.critrevonc.2025.104930_bib104","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1158\/1078-0432.CCR-21-2241","article-title":"Anlotinib induces a t cell\u2013inflamed tumor microenvironment by facilitating vessel normalization and enhances the efficacy of PD-1 checkpoint blockade in neuroblastoma","volume":"28","author":"Su","year":"2022","journal-title":"Clin. Cancer Res."},{"issue":"43","key":"10.1016\/j.critrevonc.2025.104930_bib105","doi-asserted-by":"crossref","DOI":"10.1126\/sciimmunol.aav3937","article-title":"Blockade of EGFR improves responsiveness to PD-1 blockade in EGFR-mutated non\u2013small cell lung cancer","volume":"5","author":"Sugiyama","year":"2020","journal-title":"Sci. Immunol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104930_bib106","article-title":"Fucoidan inhibits CCL22 production through NF-\u03baB pathway in M2 macrophages: a potential therapeutic strategy for cancer","volume":"6","author":"Sun","year":"2016","journal-title":"Sci. Rep."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104930_bib107","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1186\/s40425-019-0780-0","article-title":"Secondary resistance to immunotherapy associated with \u03b2-catenin pathway activation or PTEN loss in metastatic melanoma","volume":"7","author":"Trujillo","year":"2019","journal-title":"J. Immunother. Cancer"},{"issue":"5","key":"10.1016\/j.critrevonc.2025.104930_bib108","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.4049\/jimmunol.176.5.2902","article-title":"Murine B16 melanomas expressing high levels of the chemokine stromal-derived factor-1\/CXCL12 induce tumor-specific T cell chemorepulsion and escape from immune control1","volume":"176","author":"Vianello","year":"2006","journal-title":"J. Immunol."},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104930_bib109","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nm.2074","article-title":"Tumor-mediated liver x receptor-alpha activation inhibits CC chemokine receptor-7 expression on dendritic cells and dampens antitumor responses","volume":"16","author":"Villablanca","year":"2010","journal-title":"Nat. Med."},{"key":"10.1016\/j.critrevonc.2025.104930_bib110","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.43653","article-title":"CCL5 promotes breast cancer recurrence through macrophage recruitment in residual tumors","volume":"8","author":"Walens","year":"2019","journal-title":"Elife"},{"issue":"10","key":"10.1016\/j.critrevonc.2025.104930_bib111","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19103028","article-title":"Role of extracellular matrix in development and cancer progression","volume":"19","author":"Walker","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.critrevonc.2025.104930_bib112","article-title":"Chemokine receptor CCR2b enhanced anti-tumor function of chimeric antigen receptor T cells targeting mesothelin in a non-small-cell lung carcinoma model","volume":"12","author":"Wang","year":"2021","journal-title":"Front. Immunol."},{"issue":"19","key":"10.1016\/j.critrevonc.2025.104930_bib113","doi-asserted-by":"crossref","first-page":"5021","DOI":"10.3390\/cancers13195021","article-title":"ACKR4 in tumor cells regulates dendritic cell migration to tumor-draining lymph nodes and T-cell priming","volume":"13","author":"Wangmo","year":"2021","journal-title":"Cancers"},{"issue":"9","key":"10.1016\/j.critrevonc.2025.104930_bib114","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2022.104995","article-title":"Cyclophosphamide depletes tumor infiltrating T regulatory cells and combined with anti-PD-1 therapy improves survival in murine neuroblastoma","volume":"25","author":"Webb","year":"2022","journal-title":"IScience"},{"issue":"6","key":"10.1016\/j.critrevonc.2025.104930_bib115","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1002\/stem.63","article-title":"Human gastrointestinal neoplasia-associated myofibroblasts can develop from bone marrow-derived cells following allogeneic stem cell transplantation","volume":"27","author":"Worthley","year":"2009","journal-title":"Stem Cells"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104930_bib116","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/hep.30593","article-title":"Blocking triggering receptor expressed on myeloid Cells-1-positive tumor-associated macrophages induced by hypoxia reverses immunosuppression and anti-programmed cell death ligand 1 resistance in liver cancer","volume":"70","author":"Wu","year":"2019","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.critrevonc.2025.104930_bib117","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/s41392-020-00312-6","article-title":"Targeting NF-\u03baB pathway for the therapy of diseases: mechanism and clinical study","volume":"5","author":"Yu","year":"2020","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.critrevonc.2025.104930_bib118","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/j.biopha.2014.12.008","article-title":"The role of CCL20\/CCR6 axis in recruiting treg cells to tumor sites of NSCLC patients","volume":"69","author":"Zhang","year":"2015","journal-title":"Biomed. Pharmacother."}],"container-title":["Critical Reviews in Oncology\/Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104084282500318X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S104084282500318X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T02:25:23Z","timestamp":1773109523000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S104084282500318X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":118,"alternative-id":["S104084282500318X"],"URL":"https:\/\/doi.org\/10.1016\/j.critrevonc.2025.104930","relation":{},"ISSN":["1040-8428"],"issn-type":[{"value":"1040-8428","type":"print"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The critical role of homing in TIL therapy success: From biology to clinical application","name":"articletitle","label":"Article Title"},{"value":"Critical Reviews in Oncology\/Hematology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.critrevonc.2025.104930","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104930"}}